Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2014

Jul 24, 2014

33090_dirs_2014-07-24_c58f32e3-95a3-4d10-9248-edb690aba991.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2014-07-24

Reporting Person: Radoff Bradley Louis (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-07-24 Common Stock, par value $0.001 per share S 631100 $1.4095 Disposed 2289200 Direct

Footnotes

F1: $1.4095 is the weighted average sale price for the 631,100 shares sold on July 24, 2014. The shares were sold in 8 transactions at prices ranging from $1.40 to $1.50 per share, inclusive. The reporting person will provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.